Trials / Completed
CompletedNCT01729208
An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression
A Multicentre Dispensing Clinical Evaluation of MiSight® Lenses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- CooperVision, Inc. · Industry
- Sex
- All
- Age
- 8 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.
Detailed description
Subjects were randomized to wear test or control soft contact lens to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dual Focus Soft Contact Lens | |
| DEVICE | Single Vision Soft Contact Lens |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2017-05-01
- Completion
- 2019-05-01
- First posted
- 2012-11-20
- Last updated
- 2020-02-24
- Results posted
- 2020-02-24
Locations
4 sites across 4 countries: Canada, Portugal, Singapore, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01729208. Inclusion in this directory is not an endorsement.